Filing Details

Accession Number:
0001209191-22-050943
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-21 18:07:14
Reporting Period:
2022-09-19
Accepted Time:
2022-09-21 18:07:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1649094 Vaxcyte Inc. PCVX Biological Products, (No Disgnostic Substances) (2836) 464233385
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1813798 Jim Wassil C/O Vaxcyte, Inc.
825 Industrial Road, Ste. 300
San Carlos CA 94070
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-09-19 2,800 $2.42 45,144 No 4 M Direct
Common Stock Disposition 2022-09-19 2,680 $26.09 42,464 No 4 S Direct
Common Stock Disposition 2022-09-19 120 $26.56 42,344 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2022-09-19 2,800 $0.00 2,800 $2.42
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
224,726 2029-12-16 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. The price reported is a weighted-average price. The shares were sold at prices ranging from $25.56 to $26.55. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter.